Orphazyme Complete Enrolment In Phase II Clinical Trial
30 August 2019
Orphazme have just announced their interim report detailing their activities and achievements for the first half of 2019 and we’re thrilled about one of their milestones: they have completed enrolment in their Phase II Gaucher clinical trial of arimoclomol which was initiated in June 2018 across 9 centres in India, involving approximately 40 patients.
We look forward to sharing results from this in the first half of 2020.
You can read the full report here https://www.orphazyme.com/news-feed/2019/8/28/orphazyme-announces-interim-report-first-half-2019